Teladoc Health, Inc. (NYSE:TDOC) Director Buys $30,760.00 in Stock

Teladoc Health, Inc. (NYSE:TDOC) Director Thomas Mckinley bought 4,000 shares of Teladoc Health stock in a transaction that occurred on Thursday, September 12th. The shares were acquired at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the transaction, the director now directly owns 39,077 shares in the company, valued at $300,502.13. The transaction was disclosed in a filing with the SEC, which is available at this link.

Thomas Mckinley also recently made the following trade(s):

• On Tuesday, August 6th, Thomas Mckinley purchased 7,000 shares of Teladoc Health stock. The shares were acquired at an average price of $7.57 per share, for a total transaction of $52,990.00.

Teladoc Health Stock Performance

TDOC opened at $8.09 on Monday. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $22.54. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62. The firm has a fifty day moving average price of $8.07 and a 200 day moving average price of $11.07. The stock has a market cap of $1.39 billion, a P/E ratio of -5.74 and a beta of 0.90.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.08. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. The business had revenue of $642.44 million for the quarter, compared to analyst estimates of $649.34 million. Equities research analysts anticipate that Teladoc Health, Inc. will post -0.73 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts recently commented on TDOC shares. Canaccord Genuity Group lowered their target price on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a report on Friday, August 2nd. DA Davidson reduced their target price on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a research note on Thursday, August 1st. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research note on Thursday, August 1st. Finally, Barclays cut their price objective on Teladoc Health from $20.00 to $10.00 and set an “overweight” rating on the stock in a report on Thursday, August 1st. Fourteen investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $12.44.

Institutional Trading of Teladoc Health

Several institutional investors have recently bought and sold shares of TDOC. Rubric Capital Management LP acquired a new position in shares of Teladoc Health during the 2nd quarter worth approximately $45,267,000. Point72 Asset Management L.P. increased its holdings in Teladoc Health by 221.9% in the 2nd quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider’s stock worth $51,865,000 after acquiring an additional 3,655,436 shares in the last quarter. Clearline Capital LP raised its position in Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after acquiring an additional 3,483,665 shares during the period. Vanguard Group Inc. lifted its holdings in Teladoc Health by 11.8% during the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after purchasing an additional 1,855,480 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of Teladoc Health by 25.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock valued at $82,636,000 after purchasing an additional 767,999 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.